Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 25Unknown 16Recruiting 11Withdrawn 4Active not recruiting 2Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Postoperative Complications 1Neoplasms 1Gallbladder Neoplasms 1Female Breast Cancer 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Agnosia 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Sevoflurane × Clear all
NCT03005860 2023-12-21

Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery

Tata Memorial Centre

Phase NA Withdrawn
Breast

Female Breast Cancer

NCT02174575 2023-05-03

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Tokyo Medical and Dental University

Phase 4 Withdrawn
Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT00555984 2017-04-20

TIVA

The Cleveland Clinic

Phase NA Withdrawn
CNS

Brain Neoplasms, Postoperative Complications

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn
Gynecologic

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡